Observational studyBMJ open2026

Multicentre, prospective, observational study on the effectiveness and safety of upadacitinib for active perianal fistulising Crohn's disease in patients with prior anti-tumour necrosis factor failure: a study protocol.

Chong Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.